Dr. Jianyu Rao is a tenured full professor and vice chair of the department of pathology and laboratory medicine at University of California at Los Angeles (UCLA). After graduated from Shanghai Medical University in 1984, he worked at Cancer Institute, Chinese Academy of Medical Sciences and involved in multiple international cancer prevention and biomarker studies. He received provost-research post-doctoral fellowship from Oklahoma University Health Science Center in 1987, and became a research assistant professor in 1993. In 1994, he came to UCLA Medical Center to start his pathology (AP/CP) and cytopathology resident and fellowship training, became research faculty (Assistant Researcher) in 1995, and tenure-tracked Assistant Professor in 1999. In addition to be the vice chair of diagnostic technology innovation, he also currently serves as the chief of cytopathology, the director of international telepathology, and the medical director of Great Los Angeles cytotechnology school. His research focuses on cancer biomarker studies with over 170 peer-reviewed research publications. He has been invited to be a speaker for over 170 meetings and occasions locally, nationally and internationally for topics including cytology, gynecological and urinary tract pathology, cancer biology and therapy, and cancer biomarkers. He is also interested in developing new technologies for pathology especially cytopathology, including imaging and digital analysis, telepathology, nanotechnology, and AI-technology. His main accomplishments include established the first-ever international Telepathology program for patient second opinion consultation, uncovered the role of cytoskeletal actin remodeling in cancer cell differentiation, metastasis and invasion, determined molecular mechanisms of the anti-cancer effect of green tea extract, and pioneered the work for developing cellular mechanobiological profiles as a biomarker for cancer
Dr. Foran is Professor of Pathology, Laboratory Medicine & Radiology and Chief of the Division of Medical Informatics at Rutgers-Robert Wood Johnson Medical School. He also serves as Executive Director of Computational Imaging & Biomedical informatics; and Chief Informatics Officer at The Cancer Institute of New Jersey. His research focuses on the design, development, and implementation of new approaches in computer-assisted diagnostics, medical imaging and statistical pattern recognition for resolving challenging clinical problems in pathology, radiology, and oncology. He has served as a speaker and session chair for the IEEE international conferences for the engineering in medicine and biology society (EMBS); as the director and session chair for the scientific program for the annual conferences of the national Association for Pathology Informatics (API); as an invited speaker for the American Society for Investigative Pathology (ASIP); as an organizer and session chair for the World Conference on Medical Physics and Biomedical Engineering and the MICCAI International Workshop on High-Performance and Distributed Computing for Medical Imaging. Dr. Foran has served as a charter member on the Biomedical Computing and Health Informatics (BCHI) study section at the National Institutes of Health (NIH). In 2013, he will serve as a reviewer for the Biodata Management and Analysis (BDMA) Study Section for the National Institute of Biomedical Imaging and Bioengineering at NIH. He currently serves as a consultant to the U.S. Food and Drug Administration (FDA); as an Associate Editor for the journal on Cancer Informatics; as an Associate Editor Journal of Pathology Informatics; and as a reviewer for the American Medical Informatics Association; BMC Cancer; Archives in Pathology and Laboratory Medicine; the IEEE Transactions on Information Technology in Biomedicine; and the IEEE Transactions on Medical Imaging.
David J. Foran(Research Area)
1) Design/development/implementation of new approaches in statistical pattern recognition, automated image interpretation and computer assisted decision support for resolving problems in computational biology and diagnostic pathology/ radiology 2) Development of web-based data-mining technologies and computational methods for characterizing lymphoproliferative disorders elucidating the role that protein and molecular expression plays in determining the morphologic profiles exhibited by a range of malignancies.
Dr. Anshoo Agarwal is currently working as Professor & Chairperson at Department of Pathology, Northern Border University, Arar Kingdom of Saudi Arabia. She received her Bachelor of Medicine & Bachelor of Surgery from King George's Medical College Lucknow. Dr. Anshoo Agarwal received her M.D in Pathology from LLRM Medical College / Ch. Charan Singh University. She is an Associate professor and Discipline Coordinator in University Technology MARA,Malaysia. Dr. Anshoo Agarwal has served on many scientific memberships like Life member of Indian Association of Pathology and Microbiology, Member of International Academy Pathology, Life member of Indian Society of Hematology & Transfusion Medicine,Emirates Medical Association Pathology Society. Dr. Anshoo Agarwal has more than 80 publications. Dr. Anshoo Agarwal is editorial member of 3 journals and has many reviewed publications. Dr. Anshoo Agarwal research interests include Advance Haematology & Immunohaematology, Breast cancer and Anticancer vaccines.
Anshoo Agrawal(Research Area)
Oncopathology, Forensic Pathology, Genetics and Medical education
Dr. Bertha Garcia, Professor, Department of Pathology and Laboratory Medicine has been reappointed as Vice Dean, Education at the Schulich School of Medicine & Dentistry, Western University, until June 30, 2017. Dr. Garcia received her medical degree from the Cayetano Heredia University in Peru in 1972. She went on to complete her residency training in general and anatomical pathology from the University of Calgary in 1981, where she was appointed as faculty member. She joined the Department of Pathology and Laboratory Medicine at Schulich Medicine & Dentistry, Western University in 1985, and held the role of Chair and City-Wide Chief for the Department and London Hospitals from July 1, 2001 to June 30, 2011. She has held the role of Vice Dean, Education at Schulich Medicine & Dentistry since July 1, 2008. During Dr. GarciaÃ¢â‚¬â„¢s decanal leadership, the Distributed Medical Education program at Schulich Medicine & Dentistry has developed and grown significantly leading to the establishment of the Windsor Campus, as well as numerous new partnerships and learning opportunities for students and residents. Dr. Garcia is currently leading the School in a strategic planning process for Distributed Education, which is in alignment with Schulich Medicine & Dentistry and WesternÃ¢â‚¬â„¢s strategic plans. In 2015, the Undergraduate Medical Education Program received a full eight-year accreditation from the Committee on Accreditation of Canadian Medical Schools (CACMS) in collaboration with the Liaison Committee for Medical Education (LCME). Dr. Garcia is recognized as an exceptional educator with an extraordinary passion for medical education. She has received numerous local and national education awards in recognition of her leadership in medical education including the Dean's Award of Excellence in Teaching from Schulich Medicine & Dentistry, the Edward G. Pleva Award, from Western University, the OCUFA citation for outstanding contribution to University teaching. She is also the recipient of the prestigious 3M Teaching Fellowship, which is given to individuals who demonstrate an exceptionally high-degree of leadership and commitment to the improvement of university education across disciplines.
Bertha M Garcia(Research Area)
Gastrointestinal pathology, Cytopathology, Lung pathology and Autopsy services
Dr. Wiley is Director of the Division of Neuropathology. In addition to clinical sign out, Dr. Wiley directs the Neuropathology fellowship program and runs an NIH funded research program studying neuroinflammation and viral encephalitis in particular.
Clayton A. Wiley(Research Area)
Dr. Wiley's research concentrates on the pathogenesis of neurodegenerative disorders and in particular on viral and trauma induced nervous system diseases. Viruses damage the nervous system either by direct infection of neural cells or by secondary effects of an immune response. In recent years his studies have focused on central nervous system lentiviral, arboviral, enteroviral and influenzal infections and have pioneered the use of molecular and imaging techniques to quantitatively assess viral burden and neuroinflammation. This same technology is now being applied to quantify neurological damage and the immune response to brain trauma. In addition to human studies of AIDS and AlzheimerÃƒÂ¢Ã¢â€šÂ¬Ã¢â€žÂ¢s dementia, Dr. WileyÃƒÂ¢Ã¢â€šÂ¬Ã¢â€žÂ¢s lab uses H5N1 and H1N1 infected mice, ferrets and non-human primates to model viral encephalitis. Using MRI, PET and laser confocal microscopy they are investigating the evolution of the innate immune response, extracellular matrix degradation and macrophage trafficking in mediating neurological disease. Recent studies have focused on the role of immunization to modulate infectious (West Nile Virus, Influenza, Rift Valley Fever Virus, Human Parechovirus) and non-infectious (AlzheimerÃƒÂ¢Ã¢â€šÂ¬Ã¢â€žÂ¢s) neurological disease. Through extensive collaborations with neuroscientists throughout the Pittsburgh community, Dr. Wiley leads a team studying the interactions between aging and lentiviral infection on physiology and pathology of the nervous system.
Dr. Astle is responsible for evaluation and diagnosis of hematopathology specimens at the Medical College of Wisconsin/Froedtert Hospital and ChildrenÃ¢â‚¬â„¢s Hospital of Wisconsin, teaching medical students and pathology trainees, and helping to advance the field of pathology.
John M. Astle(Research Area)
1-Translational research involving hematopoiesis and hematopoietic neoplasms 2-Collaborative structuring of pathology/medical data
I received my MD degree in Shiraz, Iran 1981, PhD in Pathology at McGill, Canada 1986, and completed my residency in Anatomical Pathology also at McGill in 1990. I was a staff pathologist at McGill from 1988-2004. Currently I am a staff pathologist at the Ottawa General Hospital and an assistant professor at the University of Ottawa. My research is predomiantly on Pathology database systems using Java and SQL. In 1992, I wrote a comprehensive AP Database system that supported my department for 12 years. Recently, I wrote a Pathology Dashboard for Pathology. Currently I am finishing an automated workload monitoring system for pathologists, and an image analysis interface for WSI with ImageJ.
Fawaz Halwani(Research Area)
Data Analysis, Dashboards, Automation, Image Analysis
Marina Ivanovic is the Director of Thoaracic Pathology at Holden Comprehensive Cancer Center and Clinical Associate Professor of Pathology at University of Zagreb School of Medicine, Zagreb, Croatia.Education Completed in Anatomic Pathology from Boston University Medical Center.
Guang-Yu Yang is the Joseph C. Calandra Research Professor in Pathology and Toxicology, Director of Anatomic and Surgical Pathology, Director of Surgical/GI Pathology Fellowship Program, Department of Pathology at Northwestern University, USA. He completed his PhD from China Medical University, Molecular Pathology in 1992. He has published more that 100 research papers in various repute journals. His long-term objective of our research is to study molecular mechanism and chemoprevention of chronic inflammation-driven carcinogenesis.
Guang-Yu Yang(Research Area)
To develop a molecular mimicking model of ulcerative colitis-associated carcinogenesis in rodents, and further to elucidate the role of inflammation-caused and dietary iron-enhanced nitro-oxidative stress and inflammatory mediators in DNA damage, cell proliferation and inflammation-driven carcinogenesis; 2) to study the pathogenesis and molecular biomarkers of pancreatic carcinoma in genetically engineered mouse model and in human; and 3) to develop an efficient strategy on the prevention of chronic inflammation-driven carcinogenesis, particularly interested in dietary nutrients, antioxidants, green tea and inositol compounds and specifically targeted on colorectal, pancreatic, and liver carcinogenesis.
After general medical training, including an intercalated BSc in Anatomy and MSc in Cell and Structural Biology, I trained as a histopathologist and did a PhD in molecular biology, specifically in bone biology. Since then I have developed a diagnostic and research interest in haematopathology and my specialist diagnostic clinical interest is in leukaemia and lymphoma. I am Reader in Pathology at the University of Manchester and Consultant Haematopathologist at Manchester Royal Infirmary. I was visiting professor at the Broad Institute of Harvard & MIT 2003-2004 and am General Secretary of the Pathological Society of Great Britain and Ireland, for which I have instituted undergraduate membership.
Richard Byers(Research Area)
My research is in the field of translational molecular pathology and is focused on application of novel molecular and digital technologies to routine diagnostic use. Specifically, I have more recently been developing software for automated identification of prognostic patterns of cells in cancer using multiplex immunofluorescence and multispectral imaging.